J(
Therapeutic Areas
Genosco Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lazertinib (Leclaza) | Non-Small Cell Lung Cancer (NSCLC) | Approved |
| Cevidoplenib | Immune Thrombocytopenia (ITP) | Phase not specified |
| SKI-G-801 | Acute Myeloid Leukemia (AML) | Phase not specified |
| GNS-3545 (ROCK2 Inhibitor) | Idiopathic Pulmonary Fibrosis (IPF) | Phase 1 |
| FGFR2/3 Inhibitor | Cholangiocarcinoma & Other Solid Tumors | Pre-clinical |
| TPD/MGD Program | MYC-driven cancers | Pre-clinical |